Clinical Trial

Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The study team hypothesize that participants that receive the intervention will have better improvements immediately after treatment at week 8 in all cognitive function measures, non-cognitive symptoms, and self-management compared to those in the waitlist control.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12 -> 2027-06 2026-04-29
minor Completion pushed: 2026-12 -> 2027-06 2026-04-29
Trial Details
NCT Number NCT06880627
Lead Sponsor University of Michigan
Collaborators: National Scleroderma Foundation
Conditions Scleroderma
Enrollment 66 participants
Start Date 2025-04-16
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-28